Chapter 54: Drugs acting on the upper respiratory tract

studied byStudied by 0 people
0.0(0)
learn
LearnA personalized and smart learning plan
exam
Practice TestTake a test on your terms and definitions
spaced repetition
Spaced RepetitionScientifically backed study method
heart puzzle
Matching GameHow quick can you match all your cards?
flashcards
FlashcardsStudy terms and definitions

1 / 48

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

49 Terms

1

What are antitussives?

They block the reflex to cough.

New cards
2

What are decongestants?

Decreased the blood flow to the upper respiratory tract and decrease the overproduction of secretions.

New cards
3

What are antihistamines?

These bloc the release or action of histamines that increases secretions and narrows airways.

New cards
4

What is expectorants?

Increase productive cough to clear ariways?

New cards
5

What are mucolytics?

Increase or liquefy respiratory secretions to aid clearing of airways.

New cards
6

What are the two antitussives that we need to know?

Codeine (opioid) and Dextromethorphan (nonopiod)

New cards
7

What are the actions of antitussives?

They act directly on the medullary cough center of the brain to depress the cough reflex.

New cards
8

What are the indications of antitussives?

Control nonproductive cough

New cards
9

What are the contraindications of antitussives?

Patients who need to cough to maintain the airway and head injury or impaired CNS.

New cards
10

What are the cautions of antitussives?

Hypersensitivity or history of narcotic addictions

New cards
11

What are the adverse effects of antitussives?

Drying effect on the mucous membranes and CNS adverse effects and GI upset.

New cards
12

What are the drug to drug interactions with antitussives?

MAOIs

New cards
13

What should you asses when dealing with antitussives?

History, physical exam, allergies, temperature, respiration, adventitious lung sounds.

New cards
14

What are topical nasal decongestants? (phenylephrine)

They decrease the overproduction of secretions by causing vasoconstriction to the upper respiratory tract.

New cards
15

Topical nasal decongestants actions (phenylephrine)

Sympathomimetic, affects sympathetic nervous system to cause vasodilatation, causing less inflammation of the nasal membrane.

New cards
16

Topical nasal decongestants Indications (phenylephrine)

These relieve the discomfort of nasal congestion that accompanies the common cold, sinusitis and allergic rhinitis.

New cards
17

Topical nasal decongestants Pharmacokinetics (phenylephrine)

This is generally not absorbed systemically and any potion of these topical decongestants that is absorbed is metabolized and excreted normally.

New cards
18

Topical nasal decongestants contraindications (phenylephrine)

Lesions or erosion in the mucous membranes.

New cards
19

Topical nasal decongestants cautions (phenylephrine)

Any conditions that might be exacerbated by sympathetic activity.

New cards
20

Topical nasal decongestants adverse effects (phenylephrine)

Local stinging and burning, rebound congestion and sympathomimetic effects.

New cards
21

Oral decongestants (pseudophedrine)

These decrease nasal congestion related to the common cold, sinusitis and allergic rhinitis.

New cards
22

Oral decongestants (pseudophedrine) Actions

Shrink the nasal mucous membrane by stimulating the alpha-adrenergic receptors in the nasal mucous membranes.

New cards
23

Oral decongestants (pseudophedrine) Indications

Promotion of drainage in the sinuses and improving air flow.

New cards
24

Oral decongestants (pseudophedrine) contraindications

Any condition that might be exacerbated by sympathetic activity.

New cards
25

Oral decongestants (pseudophedrine) adverse effects

There is no rebound congestion and there is sympathetic effects

New cards
26

Oral decongestants (pseudophedrine) Drug to drug interactions

OTC products that contain pseudoephedrine; taking concurrently can cause serious side effects.

New cards
27

Topical nasal steroid decongestants (fluticasone) actions

Relieves inflammation and exact mechanism of action is not know.

New cards
28

Topical nasal steroid decongestants (fluticasone) indications

Seasonal allergic rhinitis and inflammation after the removal of nasal plyps

New cards
29

Topical nasal steroid decongestants (fluticasone) pharmacokinetics

Generally not absorbed systemically

New cards
30

Topical nasal steroid decongestants (fluticasone) Contraindiation

Acute infection.

New cards
31

Topical nasal steroid decongestants (fluticasone) pharmacokinetics

Generally not absorbed systemically

New cards
32

Topical nasal steroid decongestants (fluticasone) cautions

Active infection and avoid exposure to airborne infections

New cards
33

Topical nasal steroid decongestants (fluticasone) adverse effects

Local burning, irritation, stinging, dryness of the mucosa, headache, suppression of healing (if patient has had nasal surgery or trauma)

New cards
34

Antihistamines (dihenhydramine)

These relieve respiratory symptoms and treat allergies.

New cards
35

Antihistamines (dihenhydramine) actions

Selectively block the effects of histamine at the histamine receptor site, which decrease allergic response. These are both anticholinergic and antipruritic.

New cards
36

Antihistamines (dihenhydramine) Indications

Seasonal and perennial allergic rhinitis, allergic conjunctivitis, uncomplicated urticaria and angioedema.

New cards
37

Antihistamines (dihenhydramine) cautions

Renal/Hepatic impairment and history of arrhythmias.

New cards
38

Antihistamines (dihenhydramine) adverse effects

Drowsiness and sedation, anticholinergic effects

New cards
39

Antihistamines (dihenhydramine) drug to drug interactions

These can vary based on the drug

New cards
40

Expectorants (Guaifenesin)

These increase productive cough to clear the airways. They liquefy lower respiratory tract secretions, reducing the viscosity of the secretions and make it easier for the patient to cough.

New cards
41

Expectorants (Guaifenesin) actions

Enhances the output of respiratory tract fluids by reducing the adhesiveness and surface tension of the fluids. Allowing easier movements of the less viscous secretions.

New cards
42

Expectorants (Guaifenesin) Indications

Symptomatic relief of respiratory conditions characterized by dry, non-productive cough.

New cards
43

Expectorants (Guaifenesin) adverse effected

GI symptoms, headache, dizziness, mild rash. A prolonged use may result in masking a serious underlying disorder.

New cards
44

Mucolytics (acetylcysteine)

Increase or liquefy respiratory secretion to aid the clearing of airways in high-risk respiratory patients who are coughing up thick, tenacious secretions.

New cards
45

Mucolytics (acetylcysteine) actions

Work to break down mucous in order to aid the high-risk respiratory patient in coughing up tick, tenacious secretions

New cards
46

Mucolytics (acetylcysteine) Indications

Patient who have difficulty cough up secretions, developed atelectasis, undergoing diagnostic bronchoscopy, Post op patients and patients with trachs.

New cards
47

Mucolytics (acetylcysteine) Pharmacokinetics

Via nebulization or direct instillation into trachea.

New cards
48

Mucolytics (acetylcysteine) causations

Acute bronchospasm, peptic ulcer and esophageal varicies.

New cards
49

Mucolytics (acetylcysteine) Adverse effects

GI upset, stomatitis or rhinorrhea, bronchospasm and rash.

New cards
robot